StonvexLoading…
StonvexStonvexStonvexCore line items from MGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.54B | $17.24B | $16.16B | $13.13B |
Operating Income | $1.00B | $1.49B | $1.89B | $1.44B |
Net Income | $205.86M | $746.56M | $1.14B | $1.47B |
EPS (Diluted) | $0.76 | $2.40 | $3.19 | $3.49 |
Total Assets | $41.37B | $42.23B | $42.37B | $45.69B |
Total Liabilities | $38.10B | $38.51B | $38.00B | Not available |
Cash & Equivalents | $2.06B | $2.42B | $2.93B | $5.91B |
Free Cash Flow OCF − CapEx | $1.46B | $1.21B | $1.76B | $991.39M |
Shares Outstanding | 258.32M | 294.37M | 326.55M | 379.09M |